These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 19893063)

  • 21. [Clinical significance of Willebrand's factor antigen in patients with primary Sjogren's syndrome].
    Shilkina NP; Baranov AA; Varshavskaia AA; Makarushin AA; Nasonov EL; Panchenko KI; Nikolaev AG
    Ter Arkh; 1997; 69(12):15-8. PubMed ID: 9503526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Decreased IL-2 production in Sjögren's syndrome].
    Miyasaka N; Yamada T; Sato K; Murata H; Yada J; Nishida T; Okuda M
    Ryumachi; 1984 Jun; 24(3):166-72. PubMed ID: 6334371
    [No Abstract]   [Full Text] [Related]  

  • 23. Cryoglobulinemia in primary Sjögren's syndrome: a monoclonal process.
    Tzioufas AG; Costello R; Manoussakis MN; Papadopoulos NM; Moutsopoulos HM
    Scand J Rheumatol Suppl; 1986; 61():111-3. PubMed ID: 3109019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic value of quantitative immunohistological examination of lip biopsy in Sjögren's syndrome.
    Bodeutsch C; de Wilde PC; Kater L; van den Hoogen FH; de Jong AJ; Borstlap WA; van de Putte LB; Vooijs GP
    Neth J Med; 1991 Apr; 38(3-4):110-6. PubMed ID: 1881496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary and serum interleukin 6 in primary Sjögren's syndrome.
    Grisius MM; Bermudez DK; Fox PC
    J Rheumatol; 1997 Jun; 24(6):1089-91. PubMed ID: 9195514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal expansion of B cells in Sjögren's syndrome: comment on the article by Martin et al.
    Voulgarelis M; Tzioufas AG; Moutsopoulos HM
    Arthritis Rheum; 2001 Feb; 44(2):490. PubMed ID: 11229485
    [No Abstract]   [Full Text] [Related]  

  • 28. Absence of anticardiolipin antibodies in patients with primary Sjögren's syndrome.
    Müller K; Oxholm P; Madsen MH; Wiik A
    Autoimmunity; 1988; 2(1):92-3. PubMed ID: 3155155
    [No Abstract]   [Full Text] [Related]  

  • 29. Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.
    Gerli R; Bertotto A; Agea E; Lanfrancone L; Cernetti C; Spinozzi F; Rambotti P
    J Clin Invest; 1990 Dec; 86(6):1870-7. PubMed ID: 1979333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome.
    Fox RI; Chen P; Carson DA; Fong S
    J Immunol; 1986 Jan; 136(2):477-83. PubMed ID: 3079786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
    Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
    Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
    Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
    Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidermal IgG deposits in patients with primary Sjögren's syndrome].
    Oxholm A; Manthorpe R; Oxholm P
    Ugeskr Laeger; 1985 Jan; 147(4):261-4. PubMed ID: 3883608
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunogenetic studies of Sjögren's syndrome.
    Nakao Y; Fujita T; Yamauchi Y; Ishikawa H; Hirohata K; Miyawaki S; Suginoshita T; Matsumoto H; Tsuji K
    Ryumachi; 1981; 21 Suppl():135-40. PubMed ID: 7344123
    [No Abstract]   [Full Text] [Related]  

  • 35. [Autoimmune thyroid diseases and Gougerot-Sjögren syndrome].
    Sanmarco M; Heim M; Bernard D; Simonin R
    Pathol Biol (Paris); 1988 Sep; 36(7):867-70. PubMed ID: 3059267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatoid factors: what do they tell us?
    Newkirk MM
    J Rheumatol; 2002 Oct; 29(10):2034-40. PubMed ID: 12375308
    [No Abstract]   [Full Text] [Related]  

  • 37. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement.
    Mégevand P; Chizzolini C; Chofflon M; Roux-Lombard P; Lalive PH; Picard F
    Eur Neurol; 2007; 57(3):166-71. PubMed ID: 17213724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin A and polymeric IgA rheumatoid factors in systemic sicca syndrome: partial characterization.
    Elkon KB; Delacroix DL; Gharavi AE; Vaerman JP; Hughes GR
    J Immunol; 1982 Aug; 129(2):576-81. PubMed ID: 7086140
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-hepatitis C virus serology in primary Sjögren's syndrome: no evidence of cross-reactivity between rheumatoid factor and specific viral proteins.
    Marson P; Ostuni PA; Vicarioto M; Ongaro G; Gambari PF
    Clin Exp Rheumatol; 1991; 9(6):661-2. PubMed ID: 1662569
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lymphocyte transformation test in Sjogren's syndrome and thyroid diseases].
    Otaki M
    Nihon Ketsueki Gakkai Zasshi; 1973 Apr; 36(2):129-38. PubMed ID: 4738464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.